|
|
Participation in the Eastern Cooperative Oncology Group
|
5U10CA107868-04
|
$234,166
|
$14,050
|
AISNER, JOSEPH
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
|
Functions of EBNA1 in replication & partitioning of EBV
|
5R01CA112564-04
|
$220,812
|
$110,406
|
AIYAR, ASHOK
|
LOUISIANA STATE UNIV HSC NEW ORLEANS
|
|
|
Studies of Occupational Cancer (Pesticides)
|
Z01 CP010119
|
$1,978,544
|
$206,811
|
Alavanja
|
DCEG (NCI)
|
|
|
Studies of Alpha-tocopherol and Beta-Carotene in Finland
|
Z01 CP010195
|
$742,362
|
$25,515
|
Albanes
|
DCEG (NCI)
|
|
|
Arizona Cancer Center Support Grant
|
3P30CA023074-30S1
|
$363,313
|
$3,633
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
|
Arizona Cancer Center Support Grant
|
3P30CA023074-30S2
|
$113,227
|
$1,132
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
|
Arizona Cancer Center Support Grant
|
3P30CA023074-30S3
|
$327,884
|
$3,279
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
|
Arizona Cancer Center Support Grant
|
3P30CA023074-30S4
|
$88,172
|
$882
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
|
Arizona Cancer Center Support Grant
|
5P30CA023074-30
|
$4,124,404
|
$41,244
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
|
SURFACE ANTIGENS OF MURINE T LYMPHOMAS
|
5R01CA040041-22
|
$311,649
|
$155,825
|
ALLISON, JAMES
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
|
SPORE in Lymphoma
|
3P50CA096888-05S1
|
$1,150,000
|
$287,500
|
AMBINDER, RICHARD
|
JOHNS HOPKINS UNIVERSITY
|
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
Z01 BC 010030
|
$722,377
|
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
|
Santa Rosa Memorial Hospital Regional CCOP
|
3U10CA063850-12S2
|
$131,400
|
$2,628
|
ANDERSON, IAN
|
SANTA ROSA MEMORIAL HOSPITAL
|
|
|
Children's Oncology Group Statistics and Data Center
|
5U10CA098413-05
|
$5,859,839
|
$292,992
|
ANDERSON, JAMES
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
|
Descriptive Studies and Record Linkage
|
Z01 CP010183
|
$674,691
|
$30,726
|
Anderson
|
DCEG (NCI)
|
|
|
BLys inhibition using TACI-Fc in patients with B-bell non-Hodgkins' Lymphoma
|
1R21CA121569-01A1
|
$281,200
|
$281,200
|
ANSELL, STEPHEN
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
|
|
Activation of Proto-Oncogenes by Chromosomal Translocation
|
Z01 SC 010378
|
$636,008
|
|
Aplan, Peter
|
CCR (NCI)
|
|
|
Mechanisms of Chromosomal Translocation
|
Z01 SC 010379
|
$313,257
|
|
Aplan, Peter
|
CCR (NCI)
|
|
|
Tumor Suppressor Protein, p53
|
Z01 BC 005599
|
$543,233
|
|
Appella, Ettore
|
CCR (NCI)
|
|
|
Clinical Cancer Cytogenetics
|
Z01 BC 010694
|
$544,006
|
|
Arthur, Diane
|
CCR (NCI)
|
|
|
Eastern Cooperative Oncology Group
|
2U10CA080775-09
|
$128,678
|
$7,721
|
ATKINS, MICHAEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
Southeast Cancer Control Consortium, Inc
|
3U10CA045808-21S1
|
$170,000
|
$3,400
|
ATKINS, JAMES
|
SOUTHEAST CANCER CONTROL CONSORTIUM
|
|
|
Southeast Cancer Control Consortium, Inc
|
5U10CA045808-21
|
$1,860,642
|
$37,213
|
ATKINS, JAMES
|
SOUTHEAST CANCER CONTROL CONSORTIUM
|
|
|
Eastern Cooperative Oncology Group Studies
|
5U10CA014548-33
|
$413,938
|
$24,836
|
AVERBOOK, BRUCE
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
SAN JUAN MB COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
5U10CA052667-17
|
$484,826
|
$4,848
|
BAEZ, LUIS
|
SAN JUAN CITY HOSPITAL
|
|
|
Southwest Oncology Group
|
2U10CA027057-28
|
$255,214
|
$25,521
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
Southwest Oncology Group
|
3U10CA027057-28S1
|
$43,000
|
$4,300
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
Interim SWOG Committee Renewals (Breast, Head & Neck, Leukemia)
|
3U10CA032102-28S1
|
$187,055
|
$18,706
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
SOUTHWEST ONCOLOGY GROUP - OPERATIONS OFFICE
|
3U10CA032102-28S2
|
$159,600
|
$15,960
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
SOUTHWEST ONCOLOGY GROUP - OPERATIONS OFFICE
|
3U10CA032102-28S3
|
$316,222
|
$31,622
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
SOUTHWEST ONCOLOGY GROUP - OPERATIONS OFFICE
|
5U10CA032102-28
|
$9,423,958
|
$942,396
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
Tumor Banking for the Southwest Oncology Group
|
5U24CA114748-03
|
$999,441
|
$99,944
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
Therapeutic Studies of Primary CNS Malignancies-NABTT
|
5U01CA105706-04
|
$70,244
|
$702
|
BARNETT, GENE
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
|
WUMC-Cancer and Leukemia Group B
|
5U10CA077440-10
|
$334,381
|
$6,688
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
|
Molecular Pathways in Suppression and Development of T Lineage Lymphomas
|
1R01CA125195-01A1
|
$313,500
|
$313,500
|
BASSING, CRAIG
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
|
Annual Primary CNS Lymphoma Collaborative Group Meeting
|
5R13CA124293-02
|
$5,000
|
$5,000
|
Batchelor, Tracy
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
|
NABTT-New Approaches to Brain Tumor Therapy (CNSC)
|
5U01CA062406-13
|
$57,263
|
$573
|
Batchelor, Tracy
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
|
Clinical Studies of Multidrug Resistance Reversal
|
Z01 BC 010620
|
$176,464
|
|
Bates, Susan
|
CCR (NCI)
|
|
|
II. Clinical and Laboratory Studies of the Histone Deacetylase Inhibitor Depsipep
|
Z01 BC 010621
|
$352,928
|
|
Bates, Susan
|
CCR (NCI)
|
|
|
Regional Oncology Research Center
|
3P30CA006973-45S1
|
$231,549
|
$11,577
|
BAYLIN, STEPHEN
|
JOHNS HOPKINS UNIVERSITY
|
|
|
Regional Oncology Research Center
|
3P30CA006973-45S2
|
$126,362
|
$6,318
|
BAYLIN, STEPHEN
|
JOHNS HOPKINS UNIVERSITY
|
|
|
Regional Oncology Research Center
|
5P30CA006973-45
|
$7,564,613
|
$378,231
|
BAYLIN, STEPHEN
|
JOHNS HOPKINS UNIVERSITY
|
|
|
UPSTATE CAROLINA COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
2U10CA035119-23
|
$1,740,827
|
$34,817
|
BEARDEN, JAMES
|
SPARTANBURG REGIONAL MEDICAL CENTER
|
|
|
Cancer Center Support Grant
|
5P30CA042014-20
|
$693,487
|
$6,935
|
Beckerle, Mary
|
UNIVERSITY OF UTAH
|
|
|
Eastern Cooperative Oncology Group Clinical Trials
|
5U10CA017145-32
|
$456,370
|
$27,382
|
BENSON, AL
|
NORTHWESTERN UNIVERSITY
|
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-43S1
|
$124,531
|
$4,981
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-43S3
|
$137,869
|
$5,515
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-43S4
|
$232,326
|
$9,293
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-43S5
|
$250,000
|
$10,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA006516-43
|
$11,526,509
|
$461,060
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Total relevant funding to Non Hodgkins lymphoma for this search: $112,959,162
|
